ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000022270
Date of registration:	01/07/2016
Prospective Registration:	No
Primary sponsor:	Saitama Medical Center
Public title:	Evaluation of the effects and predictive factors of double dose of adalimumab for the patients with Crohn's disease
Scientific title:	Evaluation of the effects and predictive factors of double dose of adalimumab for the patients with Crohn's disease - ADA2 study
Date of first enrolment:	2016/06/30
Target sample size:	20
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025662
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Shingo Kato
Address:	1981 Kamoda,Kawagoe City, Japan Japan
Telephone:	0492283564
Email:	skato@saitama-med.ac.jp
Affiliation:	Saitama Medical Center Gastroenterology and Hepatology

Name:	Shingo Kato
Address:	1981 Kamoda,Kawagoe City, Japan Japan
Telephone:	049-228-3564
Email:	skato@saitama-med.ac.jp
Affiliation:	Saitama Medical Center Gastroenterology and Hepatology

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: refractory patients for adalimumab

Age minimum: 15years-old
Age maximum: 80years-old
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Crohn's disease

Intervention(s)

double dose of adalimumab

Primary Outcome(s)

effective rates

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Saitama Medical University

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.